Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

Bullboard (GREY:IPHAF)

View:
Comment by labumbaon Feb 06, 2010 7:57pm

RE: RE;Paladin

i think Lux had their durabilty study done in time before thire filing since this requirement was acknowledged by ISA in May when the partnership was formed with Paladin. And that could be the reason ...more  
Post by Sinicon Feb 06, 2010 7:17pm

RE;Paladin

Hello Thanks for the replys.  Does this mean that the requirements are different for the U.S. and Europe, since they are making submissions there already, i assume without a durability study ...more  
Comment by labumbaon Feb 06, 2010 7:00pm

RE: Paladin

my understanding is they have postponed the NDA for Psoriasis till mid-2010 due to implementing a required durability study on the drug ( shelf -life of the drug ) that normally lasts for six ...more  
Comment by throughmudon Feb 06, 2010 6:27pm

RE: Paladin

The "end of 2009" statement re submitting voclosporin for Canadian approval was made in the Paladin version of the May 7 2009 NR announcing the strategic partnership between Paladin and ...more  
Post by Sinicon Feb 06, 2010 5:54pm

Paladin

HelloI have followed this company for years.  A question please.  I was reading a news release or it could have been  an interview with Paladins CEO, after they completed the deal with ...more  
Comment by throughmudon Feb 06, 2010 5:50pm

RE: Tracking PLB and ISA

Thanks, professional11 for sharing this.mud
Post by professional11on Feb 06, 2010 4:58pm

Tracking PLB and ISA

Name -- June 30, 2006 TSX Symbol  2006 QMV ($)  2010 QMV ($)      % change 2006  rank 2008 rank  ...more  
Post by ISAloser247on Feb 05, 2010 8:03pm

Re,Re,Re,Re,Re: Psych advice

     You are right, which route did You take? Freudian, Jungian, or did You do the Horney, Fromm ,Sullivan way?     Gestalt Maybe?    Scream ...more  
Comment by professional11on Feb 05, 2010 7:09pm

Novartis/Alcon, Roche implications

https://www.fiercepharma.com/story/novartis-shopping-its-roche-stake/2010-02-03 Novartis is selling off its Roche shares to pay for the Alcon purchase. This is good news for ISA and Lux. Novartis ...more  
Post by biodelatechon Feb 05, 2010 6:45pm

A must-read

Illuminating Uveitis; Lux Seeks Luveniq Approval in U.S., Europe
Post by professional11on Feb 05, 2010 6:37pm

ISA to be featured Monday

To give you the heads up... next issue of BioWorld (Monday) is featuring an article called -  "Isotechnika Lux Out as Partner Files First Voclosporin NDA" BioWorld is read by key ...more  
Post by labumbaon Feb 05, 2010 4:26pm

go for the home run !

passed my even point....now go for a home run....Tevee , see you in Edmonton on next AGM....right..I will make tons of money as I said i will have my last laugh
Comment by wrongturnon Feb 05, 2010 3:39pm

RE: RE: not to get too excited

The Roche deal is dead and they will NOT be back.The question not becomes when will Paladin take us over?  Just pray the share price keeps climbing so it becomes more expensive to ...more  
Comment by culateron Feb 05, 2010 3:03pm

RE: not to get too excited

ROCHE, the slightest hint of Roche back knocking at the door would drive this stock to $5.00 overnight.  I think the share price would welcome any interest by a bigger Pharma company.  ...more  
Comment by throughmudon Feb 05, 2010 2:58pm

RE: Re: A deep breath always helps...

It didn't unfold quite the way they'd hoped. It's a very common story in biotech.You need to get over it. If you can't, call your shrink. You might see a couple of other posters in the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities